Design and synthesis of pyridine–pyrazolopyridine-based inhibitors of protein kinase B/Akt
Authors:
- 1 March 2007
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (6) , 2441-2452
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Phosphoinositide 3-Kinase/Akt Pathway: A New Target in Human Renal Cell Carcinoma TherapyCancer Research, 2006
- Endogenous TNFα mediates cell survival and chemotherapy resistance by activating the PI3K/Akt pathway in acute lymphoblastic leukemia cellsLeukemia, 2006
- The association between Akt activation and resistance to hormone therapy in metastatic breast cancerEuropean Journal of Cancer, 2006
- Protein kinase B/Akt at a glanceJournal of Cell Science, 2005
- Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancerInternational Journal of Cancer, 2005
- The development of phosphatidylinositol ether lipid analogues as inhibitors of the serine/threonine kinase, AktExpert Opinion on Investigational Drugs, 2004
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- The protein kinase B/Akt signalling pathway in human malignancyCellular Signalling, 2002
- Akt pathway mediates a cGMP‐dependent survival role of nitric oxide in cerebellar granule neuronesJournal of Neurochemistry, 2002
- Cardiotrophin-1 Phosphorylates Akt and BAD, and Prolongs Cell Survival via a PI3K-dependent Pathway in Cardiac MyocytesJournal of Molecular and Cellular Cardiology, 2000